Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Constanta – page 10

118 clinical trials in Constanta, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Constanta at a glance
118
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

118 trials in Constanta

Open in trial search

Study of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Study Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Seagen Inc.

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

COVID-19

Not recruiting

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Atea Pharmaceuticals Inc.

Endometrial cancer

Not recruiting

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Loperamide
  • Sponsor:Kartos Therapeutics Inc.

Oesophageal carcinoma

Not recruiting

Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Chronic hepatitis C

Not recruiting

Study on the Safety and Effectiveness of Bemnifosbuvir and Ruzasvir for Patients with Chronic Hepatitis C

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ruzasvir
  • Sponsor:Atea Pharmaceuticals Inc.

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Type 2 diabetes mellitus+2

Not recruiting

Study of Retatrutide for Patients with Type 2 Diabetes and Obesity or Overweight

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:LY3437943 sodium
  • Sponsor:Eli Lilly & Co.

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Constanta

What the registry says about research in the country

01 Neurological Disorders

Innovative clinical research focusing on multiple sclerosis treatments, including studies of remibrutinib and tolebrutinib for both relapsing and progressive forms. Additional trials investigate therapies for myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.

  • Multiple Sclerosis Management
  • Neuromuscular Disorders
  • Neuroinflammatory Conditions

Studies aim to evaluate long-term safety and efficacy of novel therapeutic approaches.

02 Infectious Diseases

Comprehensive research into viral infections, including studies on COVID-19 treatments and HIV-1 management. Trials evaluate new therapeutic options for respiratory syncytial virus (RSV) prevention in infants.

  • Viral Infections
  • Respiratory Diseases
  • Preventive Therapies

Focus on developing both treatment and preventive strategies for viral diseases.

03 Autoimmune Conditions

Studies investigating treatments for Sjögren's Disease and inflammatory bowel conditions like Crohn's Disease. Research includes evaluation of novel therapies such as mirikizumab and MORF-057.

  • Inflammatory Bowel Disease
  • Systemic Autoimmune Disorders
  • Novel Therapeutic Approaches

Trials focus on improving disease management and patient outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.